MRNA vs QURE · rev $145.0M vs rev $16.1M
Moderna Inc (MRNA) versus Uniqure NV (QURE) — a side-by-side from cached financials, not a winner call.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
Uniqure NV (QURE) is a biotechnology company listed on NASDAQ.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
Latest reported QURE revenue for 2025-12-31 was $16.1M. Net income was -$199.0M. Revenue was down 40.6% from 2024-12-31 to 2025-12-31. QURE currently screens at market cap $3.04B.
MRNA currently screens at market cap $24.52B. QURE currently screens at market cap $3.04B.
Not investment advice. Open the MRNA and QURE stock pages for the full models.
Not investment advice.